Bucholc B
Zakład Badania Surowic i Szczepionek, Państwowego Zakładu Higieny, Warszawie.
Przegl Epidemiol. 1992;46(3):231-6.
Active research is currently underway to determine the role of intravenous administration of IgG (i.v.Ig) in preventing and treating viral infections (CMV, HIV, RSV, EB, ECHO, adeno). These studies strongly suggest that immunoglobulin therapy may be beneficial in renal and bone marrow transplant patients to prevent or treat in CMV infections. Intravenous gamma globulins appears to be effective not only reducing the overall prevalence of coronary artery abnormalities in Kawasaki disease but, more important, in preventing the formation of giant aneurysms, the most serious form of coronary abnormality after this illness. However role of intravenous immunoglobulin in AIDS and in other viral diseases remains controversial. There are also dates that the high doses i.v.Ig in specific clinical situations may present certain adverse effects.
目前正在积极开展研究,以确定静脉注射免疫球蛋白(i.v.Ig)在预防和治疗病毒感染(巨细胞病毒、艾滋病毒、呼吸道合胞病毒、EB病毒、埃可病毒、腺病毒)中的作用。这些研究强烈表明,免疫球蛋白疗法可能对肾移植和骨髓移植患者预防或治疗巨细胞病毒感染有益。静脉注射丙种球蛋白似乎不仅能有效降低川崎病冠状动脉异常的总体发生率,更重要的是,能预防巨大动脉瘤的形成,这是该病后最严重的冠状动脉异常形式。然而,静脉注射免疫球蛋白在艾滋病和其他病毒性疾病中的作用仍存在争议。也有数据表明,在特定临床情况下高剂量静脉注射免疫球蛋白可能会产生某些不良反应。